CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MOODY ALDRICH PARTNERS LLC 325,977$4,860,3170.92%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$2,982,0000.90%
EMERALD MUTUAL FUND ADVISERS TRUST 809,738$12,073,1940.73%
EMERALD ADVISERS, LLC 983,775$14,668,0780.71%
Lion Point Capital, LP 82,425$1,228,9570.55%
Monashee Investment Management LLC 75,000$1,118,2500.47%
TANG CAPITAL MANAGEMENT LLC 200,000$2,982,0000.42%
Ikarian Capital, LLC 2,230$3,324,9300.40%
Artia Global Partners LP 41,261$615,2020.26%
Hood River Capital Management LLC 512,411$7,640,0480.24%
Atika Capital Management LLC 116,000$1,729,5600.23%
ADVISORY RESEARCH INC 104,540$1,558,6920.22%
Golden State Equity Partners 50,000$745,5000.21%
Holocene Advisors, LP 3,117,685$46,484,6830.20%
Ikarian Capital, LLC 104,300$1,555,1120.19%
FRED ALGER MANAGEMENT, LLC 2,172,309$32,389,1270.19%
Ikarian Capital, LLC 816$1,216,6560.15%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,125,000$61,503,7500.14%
Octagon Capital Advisors LP 60,000$894,6000.14%
AlphaCentric Advisors LLC 15,000$223,6500.13%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.